Finding the striatum in sheep: Use of a multi-modal guided approach for convection enhanced delivery

Journal of Huntington's Disease

Volumn 2, Issue 1, 2013, Pages 41-45

  Van der Bom, I M J ^a   Moser, R P ^a   Gao, G ^b   Mondo, E ^b   O'Connell D ^a   Gounis, M J ^a   McGowan, S ^b   Chaurette, J ^b   Bishop, N ^a   Sena Esteves, M S ^b   Mueller, C ^a   Aronin, N ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Huntingtin therapeutics; Sheep brain; Stereotaxis placement

Indexed keywords

ADENO ASSOCIATED VIRUS; ANIMAL; ARTICLE; CORPUS STRIATUM; DISEASE MODEL; DOMESTIC SHEEP; GENE THERAPY; GENE VECTOR; HISTOLOGY; HUNTINGTIN THERAPEUTICS; HUNTINGTON CHOREA; METHODOLOGY; SHEEP BRAIN; STEREOTACTIC PROCEDURE; STEREOTAXIS PLACEMENT; THERMODYNAMICS; TRANSGENIC ANIMAL;

HUNTINGTIN THERAPEUTICS; SHEEP BRAIN; STEREOTAXIS PLACEMENT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CONVECTION; CORPUS STRIATUM; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENETIC THERAPY; GENETIC VECTORS; HUNTINGTON DISEASE; SHEEP, DOMESTIC; STEREOTAXIC TECHNIQUES;

EID: 84906929753     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-130053     Document Type: Article

References (11)

1. McBride JL, Pitzer MR, Boudreau RL, Dufour B, Hobbs T, Ojeda SR, et al. Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington’s disease. Mol Ther. 2011;19(12): 2152-62.
2. Zhang H, Yang B, Mu X, Ahmed SS, Su Q, He R, et al. Several rAAVvectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol Ther. 2011;19(8): 1440-8.
3. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH. Convection-enhanced delivery of macromolecules in the brain. P Natl A Sci. 1994;91(6): 2076-80.
4. Bankiewicz KS, Eberling JL, Kohutnicka M, Jagust W, Pivirotto P, Bringas J, et al. Convection-enhanced delivery of AAVvector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol. 2000;164(1): 2-14.
5. Lonser RR, Walbridge S, Garmestani K, Butman JA, Walters HA, Vortmeyer AO, et al. Successful and safe perfusion of the primate brainstem: In vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg. 2002;97(4): 905-13.
6. Bankiewicz KS, Leff SE, Nagy D, Jungles S, Rokovich J, Spratt K, et al. Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson’s disease. Exp Neurol. 1997;144(1): 147-56.
7. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669): 806-11.
8. Ghildiyal M, Zamore PD. Small silencing RNAs: An expanding universe. Nat Rev Genet. 2009;10(2): 94-108.
9. van der Bom IMJ, Moser RP, Gao G, Sena-EstavesM, Aronin N, Gounis MJ. Frameless multimodal image guidance of localized convection-enhanced delivery of therapeutics in the brain. J NeuroIntervent Surg. 2013;5(1): 69-72.
10. Ruijters D, Homan R, Mielekamp P, van de Haar P, Babic D. Validation of 3D multimodality roadmapping in interventional neuroradiology. PhysMed Biol. 2011;56(16): 5335-54.
11. Morton AJ, Howland DS. Large genetic animal models of Huntington’s disease. J Huntington’s Dis. 2013;2(1): 3-19.